Skip to main content

Table 3 Hematologic toxicity

From: A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

  Grade of toxicity (NCI-CTVAE grade v2.0)
1 2 3 4
n(%) n(%) n(%) n(%)
Leucocytopenia 15(20) 27(36) 21(28) 3(4)
Neutropenia 3(4) 5(7) 20(27) 39(53)
Febrile neutropenia 0(0) 0(0) 12(16) 0(0)
Thrombocytopenia 4(5) 1(1) 0(0) 2(3)
Anemia 44(59) 20(27) 0(0) 0(0)
  1. NCI-CTCAE: National Institute Common Toxicity Criteria for Adverse Events.